FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 344:1095-1097 April 5, 2001 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: As an anatomical pathologist and paid consultant to the Ephedra Education Council, I reviewed 22 reports of adverse events received by the Food and Drug Administration (FDA) in which death had occurred and assessed the likelihood that death was related to the use of ephedrine-type alkaloids. My review, reported August 8, 2000, at the Department of Health and Human Services's Public Meeting on the Safety of Dietary Supplements Containing Ephedrine Alkaloids, in Washington, D.C., showed no consistent clinical or pathological features of the reported adverse events and showed that ephedrine-type alkaloids were not likely to have been . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Xue, Y., Cohen, S. S. (2004). Dietary Supplements: Policy and Research Implications for Nurses. Policy Politics Nursing Practice 5: 149-159 [Abstract]  
• Adachi, M., Saito, H., Kobayashi, H., Horie, Y., Kato, S., Yoshioka, M., Ishii, H. (2003). Hepatic Injury in 12 Patients Taking the Herbal Weight Loss Aids Chaso or Onshido. ANN INTERN MED 139: 488-492 [Abstract] [Full Text]  
• Hutchins, G. M. (2002). Ma Huang Toxicity. Mayo Clin Proc. 77: 733-733